SAN CLEMENTE, Calif., Jan. 6, 2014 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced that Company management will be presenting at the 32nd Annual J.P. Morgan Healthcare Conference to be held on January 13-16, 2014, at the Westin St. Francis Hotel in San Francisco, CA.
ICU Medical's presentation will take place on Thursday, January 16 at 10:30 AM Pacific Time.
The presentation will be webcast live and can be accessed by going to the Company's website at http://www.icumed.com, clicking on the Investors tab and clicking on the Event Calendar tab. The webcast will also be available by replay.
A copy of the slides to be presented may be found by going to the Company's website at http://www.icumed.com, clicking on the Investors tab, clicking on Presentations and clicking on the January 2014 Investor Presentation.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections, protecting healthcare workers from exposure to infectious diseases or hazardous. The Company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-2183 ICR, LLC John F. Mills, Senior Managing Director (310) 954-1105Source:ICU Medical, Inc.